{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:26:03Z","timestamp":1778826363290,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T00:00:00Z","timestamp":1095897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00228-004-0829-x","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T15:37:03Z","timestamp":1095867423000},"page":"635-641","source":"Crossref","is-referenced-by-count":22,"title":["A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England"],"prefix":"10.1007","volume":"60","author":[{"given":"D. N.","family":"Bateman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"McElhatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N. S.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"O\u2019Keeffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H. L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,23]]},"reference":[{"key":"829_CR1","first-page":"113","volume-title":"Diuretics. Drugs during pregnancy and lactation: handbook of prescription drugs and comparative risk assessment","author":"C Schaefer","year":"2001","unstructured":"Schaefer C, Peters P (2001) Diuretics. Drugs during pregnancy and lactation: handbook of prescription drugs and comparative risk assessment. Elsevier, Amsterdam, pp 113\u2013115"},{"key":"829_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/tera.10111","volume":"66","author":"TH Shepard","year":"2002","unstructured":"Shepard TH (2002) Annual commentary on human teratogens. Teratology 66:275\u2013277","journal-title":"Teratology"},{"key":"829_CR3","first-page":"27","volume":"143","author":"T Rost van","year":"1999","unstructured":"Rost van Tonningen, van Driel MM, Garbis Berkvens JM, Reuvers Lodewijks WB (1999) Zwangerschapsuitkomst na ecstacygebruik; 43 gevallen gevolgd door de Teratologie Informatie Service van het RIVM. Ned Tijdschr Geneeskd 143:27\u201331","journal-title":"Ned Tijdschr Geneeskd"},{"key":"829_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0892-0362(01)00178-7","volume":"23","author":"E Ho","year":"2001","unstructured":"Ho E, Karimi-Tabesh L, Koren G (2001) Characteristics of pregnant women who use Ecstasy (3,4-methylenedioxymethamphetamine). Neurotoxicol Teratol 23:561\u2013567","journal-title":"Neurotoxicol Teratol"},{"key":"829_CR5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(99)02423-X","volume":"354","author":"PR McElhatton","year":"1999","unstructured":"McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SHL (1999) Congenital anomalies after prenatal ecstasy exposure. Lancet 354:1441\u20131442","journal-title":"Lancet"},{"key":"829_CR6","unstructured":"Little BB, Toosje T, VanBeveren TT, Gilstrap LC (1998) Amphetamine abuse during pregnancy, Chap 27. In: Gilstrap LC, Little BB (eds) Drugs and pregnancy, 2nd edn. Chapman and Hall, London"},{"key":"829_CR7","doi-asserted-by":"crossref","unstructured":"Schardein JL (2000) CNS stimulants and anorectic agents, Chap 8. In: Chemically induced birth defects, 3rd edn. Marcel Dekker, New York","DOI":"10.3109\/9780203909904"},{"key":"829_CR8","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1136\/fn.81.1.F61","volume":"81","author":"AJ Sands","year":"1999","unstructured":"Sands AJ, Casey FA, Craig BG, Dornan JC, Rogers J, Mulholland HC (1999) Incidence and risk factors for ventricular septal defect in \u2018low risk\u2019 neonates. Arch Dis Child Fetal Neonatal Ed 81:F61\u2013F63","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"829_CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E","volume":"97","author":"CA Loffredo","year":"2000","unstructured":"Loffredo CA (2000) Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Gen (Semin Med Genet) 97:319\u2013325","journal-title":"Am J Med Gen (Semin Med Genet)"},{"key":"829_CR10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(96)03410-1","volume":"348","author":"E Webb","year":"1996","unstructured":"Webb E, Ashton CH, Kelly P, Kamali F (1996) Alcohol and drug use in UK university students. Lancet 348:922\u2013925","journal-title":"Lancet"},{"key":"829_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-4274(99)00205-2","volume":"15","author":"AS Christophersen","year":"2000","unstructured":"Christophersen AS (2000) Amphetamine designer drugs\u2014an overview and epidemiology. Toxicol Lett Mar 15:127\u2013131","journal-title":"Toxicol Lett Mar"},{"key":"829_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0892-0362(91)90022-O","volume":"13","author":"VE St Omer","year":"1990","unstructured":"St Omer VE, Ali SF, Holson RR, Duhart HM, Scalzo FM, Slikker W Jr (1990) Behavioural and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. Neurotoxicol Teratol 13:13\u201320","journal-title":"Neurotoxicol Teratol"},{"key":"829_CR13","volume-title":"Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study, 1981\u20131989","author":"C Ferencz","year":"1997","unstructured":"Ferencz C, Rubin JD, Loffredo CA, Magee CA (1993) Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study, 1981\u20131989. Futura Publishing Co., Mt. Kisko"},{"key":"829_CR14","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.103.19.2376","volume":"103","author":"RS Boneva","year":"2001","unstructured":"Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson D (2001) Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979\u20131997. Circulation 103:2376\u20132381","journal-title":"Circulation"},{"key":"829_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00246-002-9401-6","volume":"24","author":"P Pradat","year":"2003","unstructured":"Pradat P, Francannet C, Harris JA et al (2003) The epidemiology of cardiovascular defects, Part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 24:195\u2013221","journal-title":"Pediatr Cardiol"},{"key":"829_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0033-3506(05)80283-5","volume":"105","author":"J Tikkanen","year":"1991","unstructured":"Tikkanen J, Heinonen OP (1991) Risk factors for ventricular septal defect in Finland. Public Health 105:99\u2013112","journal-title":"Public Health"},{"key":"829_CR17","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1067\/mpd.2002.130358","volume":"141","author":"CD Chambers","year":"2002","unstructured":"Chambers CD and Jones KL (2002) Is genotype important in predicting the fetal alcohol syndrome? J Pediatr 141:1751\u20131752","journal-title":"J Pediatr"},{"key":"829_CR18","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1530-0277.2002.tb02459.x","volume":"26","author":"NL Day","year":"2002","unstructured":"Day NL, Leech SL, Richardson GA et al (2002) Prenatal alcohol exposure predicts continued deficits in offspring size at 14\u00a0years of age. Alcohol Clin Exp Res 26:1584\u20131591","journal-title":"Alcohol Clin Exp Res"},{"key":"829_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-3782(03)00003-3","volume":"71","author":"FV O\u2019Callaghan","year":"2003","unstructured":"O\u2019Callaghan FV, O\u2019Callaghan M, Najman JM et al (2003) Maternal alcohol consumption during pregnancy and physical outcomes up to 5\u00a0years of age: a longitudinal study. Early Hum Dev 71:137\u2013148","journal-title":"Early Hum Dev"},{"key":"829_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/alcalc\/agg087","volume":"38","author":"M Testa","year":"2003","unstructured":"Testa M, Quigley BM, das Eiden R (2003) The effects of prenatal alcohol exposure on infant mental development: a meta-analytical review. Alcohol Alcohol 38:295\u2013304","journal-title":"Alcohol Alcohol"},{"key":"829_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0965539502000141","volume":"13","author":"K K\u00e4ll\u00e9n","year":"2002","unstructured":"K\u00e4ll\u00e9n K (2002) Maternal smoking and congenital malformations. Fetal Matern Med Rev 13:63\u201386","journal-title":"Fetal Matern Med Rev"},{"key":"829_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1023\/A:1007671631188","volume":"15","author":"K K\u00e4ll\u00e9n","year":"1999","unstructured":"K\u00e4ll\u00e9n K (1999) Maternal smoking and congenital heart defects. Eur J Epidemiol 15:731\u2013737","journal-title":"Eur J Epidemiol"},{"key":"829_CR23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","volume":"54","author":"CP Torfs","year":"1996","unstructured":"Torfs CP, Katz EA, Bateson TF et al (1996) Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54:84\u201392","journal-title":"Teratology"},{"key":"829_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","volume":"155","author":"MM Werler","year":"2002","unstructured":"Werler MM, Sheehan JE, Mitchell AA (2002) Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155:26\u201331","journal-title":"Am J Epidemiol"},{"key":"829_CR25","first-page":"345","volume-title":"Birth defects and drugs in pregnancy","author":"OP Heinonen","year":"1997","unstructured":"Heinonen OP et al (1997) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton, pp 345\u2013356"},{"key":"829_CR26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","volume":"15","author":"A Ericson","year":"2001","unstructured":"Ericson A, K\u00e4ll\u00e9n BAJ (2001) Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 15:371\u2013375","journal-title":"Reprod Toxicol"},{"key":"829_CR27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","volume":"322","author":"GL Nielsen","year":"2001","unstructured":"Nielsen GL, S\u00f8rensen HT, Larsen H et al (2001) Risk of adverse birth outcome and miscarriage in pregnant users and non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 322:266\u2013270","journal-title":"BMJ"},{"key":"829_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","volume":"17","author":"K K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n K, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255\u2013261","journal-title":"Reprod Toxicol"},{"key":"829_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9926(199604)53:4<261::AID-TERA9>3.0.CO;2-5","volume":"53","author":"CR Wasserman","year":"1996","unstructured":"Wasserman CR, Shaw GM, O\u2019Malley CD, Tolarova MM, Lammer EJ (1996) Parental cigarette smoking and risk factor for congenital anomalies of the heart, neural tube, or limb. Teratology 53:261\u2013267","journal-title":"Teratology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0829-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0829-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0829-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:37:47Z","timestamp":1585892267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0829-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,23]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0829-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,23]]}}}